Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
drugs
Apr 17, 2024, 17:23 |
Blog
Vivek Subbiah: Should we consider them 2nd generation PARP inhibitors or a completely NEW class of drugs?
Vivek Subbiah shared a post on X: "More than a dozen PARP1 selective drugs in different…
Apr 17, 2024, 12:19 |
Blog
Angela Mastronuzzi: Special Collection on 'Pediatric Precision Oncology: Target Therapy/New Drugs in Pediatric Brain Tumors'
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, shared a post on…
Apr 15, 2024, 16:17 |
Blog
Selwyn M. Vickers: MSK hosted a screening of the documentary Living Drugs
Selwyn M. Vickers, President and CEO at Memorial Sloan Kettering Cancer Center shared on X:…
Apr 14, 2024, 15:19 |
Blog
Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs
Eddie Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared a post on X: "Delighted to present…
Apr 14, 2024, 12:56 |
Insight
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared…
Apr 14, 2024, 11:39 |
Drugs
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: "FDA…
Apr 12, 2024, 11:31 |
Blog
Scott Gottlieb: I had the opportunity to discuss the accelerated approval of cancer drugs on CNBC and share insights from a recent JAMA study
Scott Gottlieb, Partner at New Enterprise Associates, shared on LinkedIn: "Today, I had the opportunity to…
Apr 11, 2024, 12:58 |
Blog
,
Drugs
Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival - JAMA Oncology
JAMA Oncology shared on X/Twitter: "Most cancer drugs granted accelerated approval did not demonstrate benefit in…
Apr 11, 2024, 12:38 |
Blog
Key drugs at AACR 2024 by LARVOL
LARVOL shared on X/Twitter: "Exploring the key drugs at AACR 2024? Dive into the abstracts, including…
Apr 5, 2024, 08:35 |
Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
4
5
6
7
8
All:
827
Posts:
51 - 60
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube